secwatch.observer — SEC 8-K summary
======================================

Issuer:     AN2 Therapeutics, Inc. (ANTX)
CIK:        0001880438
Form:       8-K
Filed at:   2026-04-09T23:59:59+00:00
Accession:  0001193125-26-149822
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AN2 Therapeutics enters $80M ATM offering with Jefferies; prior ATM terminated
------------------------------------------------------------------------------

- Entered into Open Market Sale Agreement with Jefferies to sell up to $80M of common stock at market prices.
- Jefferies receives up to 3.0% commission; offering may be terminated by either party on 10 days' notice.
- Terminated prior TD Cowen ATM under which 2,502,000 shares were sold for aggregate $20,016,251.
- Effective April 9, 2026; no shares have been sold yet under new agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1880438/000119312526149822/0001193125-26-149822-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1880438/000119312526149822/d127053d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-149822

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer